Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Sciele Pharma, Inc. (NASDAQ:SCRX.DL)

CAPS Rating: No stars

A pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes and Women's Health.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SCRX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

kanuhops (71.11)
Submitted October 01, 2007

I like this company as its under the radar with a niche product line; they should beat estimates this quarter; but cautious once the patents start expiring and generics hit the market next year

drugncover (< 20)
Submitted May 01, 2007

Company has a weak product mix. Nearly half of revenue comes from nisoldipine, which will go generic next year. They are heavily leveraged with low interest converts, and throwing cash at minor products acquisitions. I don't think they're on the path… More

NASDAQ:SCRX.DL VS S&P 500 (SPY)

NASDAQ:SCRX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about SCRX.DL.

No one has written a Pitch for SCRX.DL stock yet. Tell us why you think SCRX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in SCRX.DL.

No players have picked SCRX.DL yet. Tell us why you think SCRX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SCRX.DL.